Phase III trial shows new drug can help patients with severe asthma reduce oral steroids
An international study has shown that a new injectable drug (benralizumab) successfully targets the receptor of the immune system protein interleukin-5 (IL-5), allowing patients with hard-to-control asthma associated with blood or sputum eosinophils to reduce or discontinue oral steroids while …
Phase III trial shows new drug can help patients with severe asthma reduce oral steroids Read more »